Pharmaceutical, Nasal
VP3 Multi-dose Spray Pump
Multidose Systems, Spray PumpsThe World’s Favorite Multi-dose Spray Pump
The reference pump for anti-allergic treatments
Our VP3 technology has been powering block buster anti-allergic drug products for decades. It’s also the reference pump for many generic nasal spray treatments. The technology complies with US FDA requirements and other global regulatory authorities, and many client reference products have been commercialized worldwide.
Proven technology and manufacturing excellence
Our global manufacturing footprint shows our successful track record of multi-site large scale GMP production, always committed to 100% quality. Our global footprint of GMP manufacturing sites use ISO7 clean rooms.
A wide range of services to support your nasal project development
We can accelerate and derisk your nasal drug development project with our comprehensive range of value added services. These include Bioequivalence testing and Regulatory guidance and support, to help you get your project to market faster.
Certified Mass-Balance Approach
Certified VP3 production site for renewable feedstock use
Aptar Pharma’s Le Vaudreuil production site in France holds the International Sustainability Carbon Certification (ISCC) PLUS. This VP3 production site supports a fully documented and traceable mass-balance approach along the supply chain, enabling the use of renewable feedstock or bio-based materials in the manufacturing of nasal spray pumps for Allergic Rhinitis.
Learn more about ISCC PLUS Certification on Aptar production sites
VP3 Multi-dose Spray Pump Advantages
Product Details
The low actuation force is something all patient like, from children through to seniors.
The fast priming feature reduces waste and possible misuse.
Ultra-clean gaskets supplied by our in-house Elastomer Center.
We Have a Broad Range of Value Added Services to Accelerate and Derisk
Your Drug Product Development.





